PRODUCT LITERATURE

Betahistine in the treatment of Ménière’s disease

---

Ménière’s disease and related disease of the vestibular system are common and debilitating. Current therapy is multi-modal and includes drug therapy and lifestyle adaptations. Unfortunately many of the drugs used in treatment (particularly those used to control nausea) are sedative and hamper the process of vestibular compensation. Although betahistine (Serc®, BetaSerc®; Solvay Pharmaceuticals) is the mainstay of drug treatment in these illnesses, its effi cacy has not, until recently, been evaluated to modern standards

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Mertigo SR

Specific Detail Info

Neuropsychiatric Disease and Treatment 2007:3(4) 429–440

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment